Merck & Co. 10Q 2016 Q1 Quarterly report | MRK Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: admission, aforementioned, antagonist, Antimicrobial, appellate, award, awarded, Basic, bench, biennial, BLA, blockade, Brian, bromide, cancellation, carcinoma, cHL, cited, classical, classification, classified, Cogan, conclusion, condensed, confirmatory, constitute, constructive, Corticotropin, Cortrophin, Crane, created, Darmstadt, declaratory, delivered, deprioritized, description, differential, dipeptidyl, discharge, discrimination, discriminatory, disparate, dissolvable, Dr, durability, dust, earliest, EMD, emetogenic, environment, equitable, ERISA, esophageal, female, France, French, German, Germany, Gilead, Harvoni, Hodgkin, hostile, house, Hydroxide, IDO, improperly, Instance, intravenously, IOmet, Ireland, Irish, Kelli, KGaA, labor, lease, Levitra, likewise, Los, lovastatin, lymphoma, Magistrate, Maxalt, metabolism, Mexico, midyear, mite, moderately, myeloma, nasopharyngeal, norfloxacin, Northern, preliminarily, premature, procedural, prospective, pulmonary, quickly, reacquire, readily, recast, reconsideration, Reddy, refractory, relapsed, repaid, repeat, retaliation, retiree, revoked, riociguat, rocuronium, Roxane, Sagent, shareholder, simplify, SLIT, Smith, sofosbuvir, Solvadi, South, Spain, Spanish, sublingual, Switzerland, TDO, undergoing, unfair, unsuccessful, vecuronium, verification, vest, withholding, word, wrongdoing, Zealand, Zepatier, Zinc, Zinplava

Removed: ABSSSI, achievement, acquire, Acquirement, affirming, alfa, allegedly, allocation, Alnylam, angina, annum, antihistamine, antipsychotic, antiviral, approximate, asenapine, assisted, auction, bacterial, Bank, bevenopran, bid, biopharmaceutical, Biotech, bipolar, bleeding, boceprevir, boxed, bringing, build, building, Canadian, carried, Centocor, central, Clarinex, competing, complex, Complimentary, composite, concept, conducted, constipation, contend, contract, contractually, controlled, convertible, corifollitropin, coronary, counsel, creation, delivery, demonstrated, design, desloratadine, diet, discontinue, disorder, disposition, divestiture, divided, downplayed, duration, Ebola, elevated, Elonva, EMA, endpoint, essential, evidentiary, exchanging, exclusively, exercised, exercising, exhausted, expand, expert, extending, failed, feasibility, fewer, finasteride, foot, Forest, generated, Gleeson, greatest, hair, healthy, heart, hematological, hire, hormonal, hospitalization, hyperlipidemia, hypersensitivity, immune, inclusion, inclusive, incomplete, incremental, independent, industry, inferred, inherited, institute, investigating, John, Johnson, joined, kidney, launching, leave, lump, MAA, Marginal, maximum, MCC, meaningful, Missouri, mix, monoclonal, morbidity, mortality, NDA, negative, negotiating, NewLink, noncontrolling, noncurrent, nucleotide, occurring, official, ophthalmic, opiate, opioid, Ortho, overseeing, participating, partner, pattern, peginterferon, PegIntron, phosphate, posed, precombination, preferred, prefilled, prescribing, presenting, prodrug, projected, proof, prosecute, Protocol, published, purpose, randomization, randomized, recommendation, renal, replaced, replication, reproductive, resubmission, resubmitted, retainer, retired, revascularization, rheumatoid, rolling, ruled, Sandoz, scale, schizophrenia, scientific, secondary, sensitivity, shutdown, SIMADI, Sirna, Sistema, Sivextro, statistically, stay, stimulation, strategic, stroke, studied, substitution, sun, surotomycin, syringe, system, technological, technology, tedizolid, terminated, thromboembolism, tract, transact, triple, unchanged, underway, unstable, urinary, USP, valuation, VEF, Venezuelan, venued, viral, voluntary, VTE, warning, West, withdrawal, women, workforce, yield




Dated: May 9, 2016	/s/ Kenneth C. Frazier
	Name: Title:	KENNETH C. FRAZIER Chairman, President and Chief Executive Officer

Merck & Co. (MRK) 10-Q2016 Q1 Quarterly report

Content analysis